Stocks and Investing Stocks and Investing
Mon, August 5, 2024

Raghuram Selvaraju Reiterated (BBIO) at Strong Buy and Held Target at $43 on, Aug 5th, 2024


Published on 2024-10-28 13:11:49 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $43 on, Aug 5th, 2024.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 4 other peers that have a rating on BBIO. Out of the 4 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, July 1st, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, June 25th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024
  • Cory Kasimov of "Evercore ISI Group" Initiated at Buy and Held Target at $50 on, Tuesday, May 14th, 2024

Contributing Sources